Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis?

Antimicrobial Agents and Chemotherapy
L B HeifetsP J Lindholm-Levy

Abstract

The commonly accepted hypothesis explaining the mechanism of action of pyrazinamide (PZA) is based on the assumption that PZA-susceptible Mycobacterium tuberculosis strains produce pyrazinamidase, which hydrolyzes PZA to the antibacterial moiety pyrazinoic acid (POA). It is not clear whether POA has specific antimicrobial activity or the inhibition of growth caused by POA is due to its ability to lower the pH of the environment below the limits of tolerance of M. tuberculosis growth. We confirmed in this study that POA, depending on the concentration, lowered the pH of 7H12 broth (pH 6.0), which ranged from 5.8 at 120.0 micrograms/ml to 4.6 at 960.0 micrograms/ml. Therefore, we tested the inhibitory effects of different concentrations of POA in broth in which the final pH was adjusted to 5.6 by adding appropriate amounts of phosphoric acid or dipotassium phosphate. Under these conditions, we found a clear dose-response correlation, proving that POA does have specific antimicrobial activity. The MIC of POA at pH 5.6 was 240 to 480 micrograms/ml, 8- to 16-fold higher than the MIC of PZA under the same conditions and much higher than the concentrations achievable in humans. This suggests that the action of POA in an acid environme...Continue Reading

Citations

Aug 1, 1994·International Journal of Antimicrobial Agents·V St Georgiev
Jan 7, 1998·Biochemical Pharmacology·C E Barry
Oct 19, 2002·International Journal of Antimicrobial Agents·M BamagaH Zhang
Sep 1, 1995·Antimicrobial Agents and Chemotherapy·S YamamotoT Ura
Jan 16, 2007·Clinical Microbiology Reviews·Florence DepardieuPatrice Courvalin
Mar 15, 2005·Clinical Pharmacokinetics·Vincent Launay-VacherGilbert Deray
Jul 1, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Mohamed Ashraf AliMohamed Zaheen Hassan Ansari
Mar 15, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Mohamed Ashraf AliRamakant Gaur
Jun 24, 2008·Journal of Enzyme Inhibition and Medicinal Chemistry·Mohammad ShaharyarVel Murugan
Feb 14, 2008·Journal of Pharmaceutical Sciences·C BeckerD M Barends
Nov 11, 2011·Bioorganic & Medicinal Chemistry Letters·Mohamed Jawed AhsanAbhimanyu Singh
May 1, 2007·Bioorganic & Medicinal Chemistry Letters·Mohamed Ashraf Ali, Mohammad Shaharyar
Feb 13, 2007·Bioorganic & Medicinal Chemistry·Yves L Janin
Jan 26, 2007·Bioorganic & Medicinal Chemistry·Mohamed Ashraf Ali, Mohammad Shaharyar
May 27, 2006·Bioorganic & Medicinal Chemistry Letters·Mohammad ShaharyarPerumal Yogeeswari
Jun 21, 2006·Bioorganic & Medicinal Chemistry Letters·Mohammad ShaharyarMohamed Ashraf Ali
Feb 9, 2006·Bioorganic & Medicinal Chemistry Letters·Dharmarajan SriramSushma Pobba Reddy
Aug 3, 2011·Bioorganic & Medicinal Chemistry Letters·Mohamed Jawed AhsanChandra Bhushan Jain
Oct 8, 2011·European Journal of Medicinal Chemistry·Mohamed Jawed AhsanMohd Zaheen Hassan
May 1, 2016·International Journal of Pharmaceutics·P G DurhamA J Hickey
Nov 13, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·S StegemannA Hincal
Jun 27, 2013·Langmuir : the ACS Journal of Surfaces and Colloids·Elianne Dahan, Pudupadi R Sundararajan
Mar 15, 2012·Journal of the American Chemical Society·Robert SilversHarald Schwalbe
Dec 20, 2012·The Journal of Physical Chemistry. B·Inger Martínez de ArenazaJose-Ramon Sarasua
Apr 25, 2013·Journal of the American Chemical Society·Peng-peng WangXun Wang
Jul 13, 2002·Biopharmaceutics & Drug Disposition·Aida MehmedagicOlivier Lafont
Jul 7, 2007·Natural Product Research·Mohamed Ashraf AliGanesan Suresh Pandian
Dec 23, 2009·The Journal of Chemical Physics·Steven Zweier, Marvin Bishop
May 2, 2009·The Journal of Chemical Physics·Nikos Ch KarayiannisManuel Laso
Apr 20, 2017·Journal of the American Chemical Society·Kai Huang, Igal Szleifer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.